Add to Calendar

Register Now

Register in advance for this webinar:
After registering, you will receive a confirmation email containing information about joining the webinar.

Monday, May 24th 7:00 p.m. EDT.

As a result of participating in this activity, learners will be able to: Review the outcomes for different subsets of patients with pancreatic cancer, recognize the potential relevance of neoadjuvant chemotherapy and radiotherapy for resectable and unresectable pancreatic cancer, and discuss the use of evidence-based national guidelines and prognostic indicators, such as the AJCC staging system

The target audience for this presentation: medical oncologists, surgical oncologists, radiation oncologists, gastroenterologists


CME statement:

USF Health is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

USF Health designates this live activity for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

USF Health (provider number 2970) is an approved provider of continuing education for nurses through Florida Board of Nursing. This activity has been approved for 1.0 contact hours.


View related document for accreditation information.



If you have any questions or credit related inquiries, please contact USF Health at


May 3, 2021

Created by

Tampa General Hospital


Andreas Karachristos, FACS, MD, PhD

Andreas Karachristos, FACS, MD, PhD

Chief of Surgical Oncology
Hepatobiliary and Pancreatic Surgery
Professor of Surgery
Department of Surgery
University of South Florida

Dr. Andreas Karachristos specializes in hepato-pancreato-biliary(HPB) or the care of the liver, pancreas, bile duct and gallbladder. 

Richard Tuli, MD, PhD

Richard Tuli, MD, PhD

Professor & Chair, Radiation Oncology
USF Health Morsani College of Medicine
Director of Research
Tampa General Hospital